Pharmadrug Inc.
LMLLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $98 |
| G&A Expenses | $13 | $3 | $26 | $12 |
| SG&A Expenses | $13 | $3 | $34 | $20 |
| Sales & Mktg Exp. | $0 | $4 | $8 | $8 |
| Other Operating Expenses | $18 | $27 | $16 | -$18 |
| Operating Expenses | $31 | $30 | $50 | $100 |
| Operating Income | -$31 | -$8 | -$50 | -$100 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$56 | -$54 | -$68 | $93 |
| Pre-Tax Income | -$87 | -$85 | -$117 | -$7 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$77 | -$73 | -$100 | $6 |
| % Margin | – | – | – | – |
| EPS | -0.001 | -0.001 | -0.001 | 0.001 |
| % Growth | -42.9% | 30% | -242.9% | – |
| EPS Diluted | -0.001 | -0.001 | -0.001 | 0.001 |
| Weighted Avg Shares Out | 108,234 | 100,111 | 100,111 | 101,655 |
| Weighted Avg Shares Out Dil | 108,234 | 107,768 | 107,768 | 104,035 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $13 |
| Interest Expense | $56 | $54 | $53 | $0 |
| Depreciation & Amortization | $13 | $13 | $13 | $13 |
| EBITDA | -$18 | -$18 | -$52 | -$8 |
| % Margin | – | – | – | – |